These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22504865)

  • 1. Lipophilicity as a determinant of binding of procaine analogs to rat α3β4 nicotinic acetylcholine receptor.
    Cheffer A; Mustafa EV; T-do Amaral A; Ulrich H
    J Neurosci Res; 2012 Aug; 90(8):1607-14. PubMed ID: 22504865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular properties of local anesthetics as predictors of affinity for nicotinic acetylcholine receptors.
    Pagán OR; Sivaprakasam K; Oswald RE
    J Neurosci Res; 2007 Oct; 85(13):2943-9. PubMed ID: 17600837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs.
    Xiao Y; Smith RD; Caruso FS; Kellar KJ
    J Pharmacol Exp Ther; 2001 Oct; 299(1):366-71. PubMed ID: 11561100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of noncompetitive inhibitors with an immobilized alpha3beta4 nicotinic acetylcholine receptor investigated by affinity chromatography, quantitative-structure activity relationship analysis, and molecular docking.
    Jozwiak K; Ravichandran S; Collins JR; Wainer IW
    J Med Chem; 2004 Jul; 47(16):4008-21. PubMed ID: 15267239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogs of methyllycaconitine as novel noncompetitive inhibitors of nicotinic receptors: pharmacological characterization, computational modeling, and pharmacophore development.
    McKay DB; Chang C; González-Cestari TF; McKay SB; El-Hajj RA; Bryant DL; Zhu MX; Swaan PW; Arason KM; Pulipaka AB; Orac CM; Bergmeier SC
    Mol Pharmacol; 2007 May; 71(5):1288-97. PubMed ID: 17308033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release.
    Zheng F; Bayram E; Sumithran SP; Ayers JT; Zhan CG; Schmitt JD; Dwoskin LP; Crooks PA
    Bioorg Med Chem; 2006 May; 14(9):3017-37. PubMed ID: 16431111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes.
    Gentry CL; Lukas RJ
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1038-48. PubMed ID: 11714893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamoylcholine analogs as nicotinic acetylcholine receptor agonists--structural modifications of 3-(dimethylamino)butyl dimethylcarbamate (DMABC).
    Hansen CP; Jensen AA; Balle T; Bitsch-Jensen K; Hassan MM; Liljefors T; Frølund B
    Bioorg Med Chem Lett; 2009 Jan; 19(1):87-91. PubMed ID: 19027295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition mechanism of rat α₃β₄ nicotinic acetylcholine receptor by the Alzheimer therapeutic tacrine.
    Cheffer A; Ulrich H
    Biochemistry; 2011 Mar; 50(11):1763-70. PubMed ID: 21247200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
    Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
    J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
    Wilkins LH; Grinevich VP; Ayers JT; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):400-10. PubMed ID: 12490617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.
    Slavov SH; Radzvilovits M; LeFrancois S; Stoyanova-Slavova IB; Soti F; Kem WR; Katritzky AR
    Eur J Med Chem; 2010 Jun; 45(6):2433-46. PubMed ID: 20236734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-conotoxin analogs with additional positive charge show increased selectivity towards Torpedo californica and some neuronal subtypes of nicotinic acetylcholine receptors.
    Kasheverov IE; Zhmak MN; Vulfius CA; Gorbacheva EV; Mordvintsev DY; Utkin YN; van Elk R; Smit AB; Tsetlin VI
    FEBS J; 2006 Oct; 273(19):4470-81. PubMed ID: 16956365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
    Grinevich VP; Crooks PA; Sumithran SP; Haubner AJ; Ayers JT; Dwoskin LP
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1011-20. PubMed ID: 12766255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of local anesthetics on the inhibition of adult muscle-type nicotinic acetylcholine receptors by nondepolarizing muscle relaxants.
    Wang H; Zhang Y; Li ST
    Eur J Pharmacol; 2010 Mar; 630(1-3):29-33. PubMed ID: 20045405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
    Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
    J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New ligands with affinity for the alpha4beta2 subtype of nicotinic acetylcholine receptors. Synthesis, receptor binding, and 3D-QSAR modeling.
    Audouze K; Nielsen EØ; Olsen GM; Ahring P; Jørgensen TD; Peters D; Liljefors T; Balle T
    J Med Chem; 2006 Jun; 49(11):3159-71. PubMed ID: 16722635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational evidence for the ligand selectivity to the alpha4beta2 and alpha3beta4 nicotinic acetylcholine receptors.
    Yuan H; Petukhov PA
    Bioorg Med Chem; 2006 Dec; 14(23):7936-42. PubMed ID: 16919961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CoMFA, CoMSIA, and molecular hologram QSAR studies of novel neuronal nAChRs ligands-open ring analogues of 3-pyridyl ether.
    Zhang H; Li H; Liu C
    J Chem Inf Model; 2005; 45(2):440-8. PubMed ID: 15807510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
    Chiara DC; Xie Y; Cohen JB
    Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.